We are live on ! Find out more
RXL icon

ProShares Ultra Health Care

18 hedge funds and large institutions have $6M invested in ProShares Ultra Health Care in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

7.38% less ownership

Funds ownership: 30.57%23.19% (-7.4%)

14% less funds holding

Funds holding: 2118 (-3)

20% less capital invested

Capital invested by funds: $7.51M → $6M (-$1.51M)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.41%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
4
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change

RXL Hedge Fund Activity: Q2 2018 in Review

18 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q2 2018, worth a combined $6M — down 20% from $7.51M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of RXL and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 4 added.

The largest buyer was Simplex Trading, adding an estimated $30.8K. The largest seller was Avalon Capital Management, exiting entirely with an estimated $702K sold.

  • 18 institutional investors held ProShares Ultra Health Care (RXL) as of Q2 2018, down from 21 in Q1 2018.
  • Funds reported $6M of ProShares Ultra Health Care stock for Q2 2018, down 20% quarter-over-quarter.
  • 1 fund opened new ProShares Ultra Health Care positions in Q2 2018 and 4 closed out, a net change of -3 holders.
  • The largest ProShares Ultra Health Care buyer in Q2 2018 was Simplex Trading, an estimated $30.8K added.
  • The largest ProShares Ultra Health Care seller in Q2 2018 was Avalon Capital Management, an estimated $702K sold.

Based on aggregated 13F filings for Q2 2018.